[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620969":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":8,"responsibleParty":25,"collaborators":7,"id":29,"slug":7,"hasResults":30,"nctId":31,"briefTitle":32,"officialTitle":33,"acronym":34,"eligibilityCriteria":35,"healthyVolunteers":36,"sex":37,"minAge":38,"maxAge":39,"enrollmentInfo":40,"targetDuration":43,"studyType":44,"phases":7,"briefSummary":45,"conditions":46,"keywords":48,"overallStatus":10,"whyStopped":7,"lastUpdateSubmitDate":50,"lastUpdatePostDateStruct":51,"startDateStruct":54,"completionDateStruct":56,"leadSponsor":58,"locationsCount":59},{"fullName":5,"class":6},"Instituto Bernabeu","OTHER",null,[9],{"facility":5,"status":10,"city":11,"state":7,"zip":7,"country":12,"cosmosGeoPoint":13,"geoPoint":18,"contacts":19},"RECRUITING","Alicante","Spain",{"type":14,"coordinates":15},"Point",[16,17],-0.48149,38.34517,{"lat":17,"lon":16},[20],{"name":21,"role":22,"phone":23,"phoneExt":7,"email":24},"BELEN LLEDO, PhD","CONTACT","965154053","blledo@institutobernabeu.com",{"type":26,"investigatorFullName":27,"investigatorTitle":28,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"PRINCIPAL_INVESTIGATOR","Belen Lledo","Director","100620969",false,"NCT07364526","Non-Invasive Preimplantation Genetic Screening for Aneuploidies and Clinical Outcomes in Egg Donation Patients","Non-invasive Preimplantation Genetic Screening (niPGTA) in Oocyte Donation Patients.","niPGTAdon","Inclusion Criteria:\n\n* Women between 18 and 50 years old who are oocyte recipients.\n* Signed consent form\n* Transfer of a single blastocyst-stage embryo\n* Male with normal sperm FISH\n\nExclusion Criteria:\n\n* Uterine malformations\n* Abnormal karyotypes in either partner\n* Failure to sign informed consent",true,"FEMALE","18 Years","50 Years",{"count":41,"type":42},164,"ESTIMATED","3 Years","OBSERVATIONAL","Preimplantation genetic testing for aneuploidies (PGT-A) is commonly used in IVF but requires embryo biopsy and shows limited benefit in egg donation cycles. Non-invasive PGT-A (niPGTA), based on the analysis of cell-free embryonic DNA in spent culture media, offers a promising biopsy-free alternative. This prospective, blinded study in egg donation cycles will evaluate whether niPGTA-detected aneuploidy is associated with implantation failure and pregnancy loss, assessing its potential clinical value as a non-invasive embryo selection tool.",[47],"IVF",[49],"niPGTA","2026-01-21",{"date":52,"type":53},"2026-01-23","ACTUAL",{"date":55,"type":42},"2026-02-26",{"date":57,"type":42},"2027-12-01",{"name":5,"class":6},1]